What happened in this Health story?

The Shanghai-based brain-computer interface startup landed a major institutional backing round, strengthening the resources behind a program that supports movement, decodes speech and controls external devices across distinct use cases.

What is a key fact in this story? (1)

**NeuroXess** raised RMB 700 million, about $105 million, in Series B funding co-led by SDIC Juli and Shenzhen.

What is a key fact in this story? (2)

**NeuroXess** is developing BCI technology for movement support, speech decoding and control of external devices.

NeuroXess Raises ~$105M for BCI Development — SkimNews

By TechMeme · Summarized & edited by Kapil Samant · 2026-11-01

Get the Health newsletter

Daily health & science — research, biotech, public health, the studies worth knowing. Free.

NeuroXess raised RMB 700 million, about $105 million, in Series B funding co-led by SDIC Juli and Shenzhen.
NeuroXess is developing BCI technology for movement support, speech decoding and control of external devices.

Why it matters: NeuroXess has secured RMB 700 million (about $105 million) in a Series B co-led by SDIC Juli and Shenzhen, giving its BCI development program a substantial new funding base. The breadth is material: movement support, speech decoding and external-device control are all active targets for the Shanghai-based company.